13F Portfolios

SurgoCap Partners LP — MCKESSON CORP MCK: Quarterly 13F Position History

SurgoCap Partners LP has reported MCKESSON CORP (MCK) on 10 13F-HR filings in Pactolio's tracked window, first appearing in Q4 2023. As of Q1 2026, the position is sized at 348,732 shares ($301.8M market value, 10.08% of the equity book). Quarter-over-quarter share count change: 70,434 (-16.8%) .

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 10 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q1 2026 348,732 70,434 -16.8% $301.8M 10.08% $865.36
Q4 2025 419,166 33,095 -7.3% $343.8M 9.52% $820.29
Q3 2025 452,261 +184,106 +68.7% $349.4M 9.92% $772.54
Q2 2025 268,155 25,982 -8.8% $196.5M 7.53% $732.78
Q1 2025 294,137 214,744 -42.2% $198.0M 9.78% $672.99
Q4 2024 508,881 99,436 -16.3% $290.0M 16.79% $569.91
Q3 2024 608,317 +126,675 +26.3% $300.8M 16.04% $494.42
Q2 2024 481,642 14,261 -2.9% $281.3M 16.45% $584.04
Q1 2024 495,903 +162,875 +48.9% $266.2M 14.29% $536.85
Q4 2023 333,028 $154.2M 10.89% $462.98

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.

When did SurgoCap Partners LP first disclose a MCK position in 13F-HR filings?

SurgoCap Partners LP first reported MCKESSON CORP (MCK) on its 13F-HR filing for the period ending 2023-12-31 (Q4 2023). The position has appeared on 10 reported quarters within Pactolio's tracked window.

What was SurgoCap Partners LP's most recent quarter-over-quarter share-count change in MCK?

Between Q4 2025 and Q1 2026, SurgoCap Partners LP reduced its MCK position by 70,434 shares (-16.8%), leaving 348,732 shares at a market value of $301.8M.

Does the implied price-per-share represent SurgoCap Partners LP's cost basis in MCK?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.